digital therapeutics

By Dave Muoio 10:28 am October 16, 2019
Editor's Note: This story has been updated with additional quotes from Pear Therapeutics. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to Pear Therapeutics. “Pear and Sandoz previously signed...

Credit: Ieso Digital Health

By Leontina Postelnicu 05:57 am October 16, 2019
The digital therapeutics field has attracted the interest of major players in the healthcare industry lately, from big pharma to the NHS. But there is debate among stakeholders around issues including reimbursement, regulation and business models that work. The space, however, continues to grow, and Cambridge-headquartered Ieso Digital Health unveiled earlier this year plans to build an...

Photo credit: Rock Health 

By Laura Lovett 11:51 am October 15, 2019
A decade ago digital health was a relatively new term, largely without name recognition. Today, the venture dollars tell a new story, with $8.1 billion poured into the space in 2018 alone, according to a Rock Health report. Still, most healthcare stakeholders agree digital health is still in its early days and is grappling with questions about its place in the health ecosystem.  Founded in 2010,...
By Dave Muoio 03:18 pm October 7, 2019
Proteus Digital Health’s ingestible pill and sensor system could improve medication adherence, and subsequently treatment, for patients with tuberculosis (TB), according to new data from an independent study conducted in California. Published Friday in PLoS Medicine, the trial found Proteus’ system to accurately determine whether or not a medication was taken. Patients using the system at home...
By Dave Muoio 02:08 pm August 20, 2019
ATENTIV, maker of a video game-based intervention for ADHD, has partnered with Children’s Specialized Hospital’s Center for Discovery, Innovation and Development (CDID) to explore a novel care model blending both behavioral and primary care. Of particular note, ATENTIV and CDID, part of the RWJBarnabas Health system in New Jersey, will be investigating how to deploy the therapy, called...
By Dave Muoio 02:00 pm August 6, 2019
Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers. WHAT THEY DO The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger...
By Dave Muoio 02:32 pm July 26, 2019
In many respects, the pharma industry’s operations are still in the early stages of technological  revolution, and there’s no better example of this than its gradual adoption of digital health and digital therapeutics. On one hand, more and more groups are regularly striking new partnerships that supplement existing drug treatments with digital tools, while Novartis continues its work with Pear...
By Dave Muoio 03:58 pm July 25, 2019
IPO fever is hitting a bit of a frenzy amidst a slew of recent listings, and with it has come a renewed focus on the exact boundaries of digital health — or, alternately, of health-tech, connected health, eHealth, or any of the other myriad monikers for the intersections of healthcare, technology and innovation. As observers from various mainstream and niche industries have flocked to discuss ...
By Dave Muoio 03:59 pm July 22, 2019
Prescription digital therapeutics company Pear Therapeutics announced late last week that it has filed an FDA marketing authorization for Somryst, its digital cognitive behavioral therapy for the treatment of adults with chronic insomnia and depression. While an approval from the agency would mark the third authorized prescription digital therapeutic for Pear — behind reSET for substance use...
By Laura Lovett 04:15 pm July 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.  While digital promises the...